These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18691789)

  • 1. Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters.
    Topkan E; Yavuz MN; Onal C; Yavuz AA
    Lung Cancer; 2009 Mar; 63(3):393-9. PubMed ID: 18691789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.
    Zhang ZC; Xu J; Li BS; Zhou T; Lu J; Wang ZT; Li HS; Sun HF; Zhu J; Yu JM
    Am J Clin Oncol; 2010 Jun; 33(3):271-5. PubMed ID: 19823071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of radiochemotherapy-induced esophagitis with glutamine: results of a pilot study.
    Algara M; Rodríguez N; Viñals P; Lacruz M; Foro P; Reig A; Quera J; Lozano J; Fernández-Velilla E; Membrive I; Dengra J; Sanz X
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):342-9. PubMed ID: 17531398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
    Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.
    Wei X; Liu HH; Tucker SL; Liao Z; Hu C; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):100-7. PubMed ID: 16839700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.
    Belderbos J; Heemsbergen W; Hoogeman M; Pengel K; Rossi M; Lebesque J
    Radiother Oncol; 2005 May; 75(2):157-64. PubMed ID: 15890421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral glutamine supplements reduce concurrent chemoradiotherapy-induced esophagitis in patients with advanced non-small cell lung cancer.
    Chang SC; Lai YC; Hung JC; Chang CY
    Medicine (Baltimore); 2019 Feb; 98(8):e14463. PubMed ID: 30813149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
    Rodríguez N; Algara M; Foro P; Lacruz M; Reig A; Membrive I; Lozano J; López JL; Quera J; Fernández-Velilla E; Sanz X
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):810-7. PubMed ID: 18755556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial.
    Alshawa A; Cadena AP; Stephen B; Reddy A; Mendoza TR; McQuinn L; Lawhorn K; Zarifa A; Bernhardt AM; Fessaheye S; Warneke CL; Chang JY; Naing A
    Invest New Drugs; 2021 Aug; 39(4):1113-1122. PubMed ID: 33580845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric and clinical predictors for radiation-induced esophageal injury.
    Ahn SJ; Kahn D; Zhou S; Yu X; Hollis D; Shafman TD; Marks LB
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):335-47. PubMed ID: 15667951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Watkins JM; Wahlquist AE; Shirai K; Garrett-Mayer E; Aguero EG; Fortney JA; Sherman CA; Sharma AK
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1108-13. PubMed ID: 19084345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of oral glutamine on clinical and survival outcomes of non-small cell lung cancer patients treated with chemoradiotherapy.
    Gul K; Mehmet K; Meryem A
    Clin Nutr; 2017 Aug; 36(4):1022-1028. PubMed ID: 27373496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of oral recombinant human granulocyte macrophage-colony stimulating factor in radiotherapy-induced esophagitis.
    Koc M; Onuk MD; Koruk M; Memik F
    Hepatogastroenterology; 2003; 50(53):1297-300. PubMed ID: 14571722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
    Zehentmayr F; Söhn M; Exeli AK; Wurstbauer K; Tröller A; Deutschmann H; Fastner G; Fussl C; Steininger P; Kranzinger M; Belka C; Studnicka M; Sedlmayer F
    Radiat Oncol; 2015 May; 10():121. PubMed ID: 26018527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy.
    Sekine I; Sumi M; Ito Y; Tanai C; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Jpn J Clin Oncol; 2009 Nov; 39(11):707-12. PubMed ID: 19692418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction therapy of loco-regional non-small-cell lung cancer with reliable response and low toxicity (low dose radiotherapy sensitizes tumor to subsequent chemotherapy?).
    Takita H; Shin KH; Soh AY; Yi WS; Wilding G
    Lung Cancer; 2009 Mar; 63(3):387-92. PubMed ID: 18676056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
    Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.